Deals
Blackstone Raises New Fund as Two Pharma Giants Close March Megadeals
Two pharma giants closed megadeals in March while Blackstone raised a new fund — more dry powder chasing the same targets means multiples only go one way.
Deals — Page 6
M&A, fundraising, IPOs, and bankruptcies in regulated industries.
Deals
Biogen Drops $5.6B for Apellis at 140% Premium, Shares Fall
Biogen acquires Apellis for $5.6B at a near 140% premium, adding Syfovre and Empaveli to offset a fading MS franchise ahead of pharma's patent cliff.
You've reached the end of the archive.
Want the next stories in your inbox? Subscribe to the newsletter